Monalizumab [1228763-95-8]

MedChem Express

Monalizumab [1228763-95-8]

10

1228763-95-8

Research Use Only

99.93

Monalizumab (IPH2201) is an immune checkpoint inhibitor targeting Natural Killer Group 2A (NKG2A). Monalizumab, a humanized anti-NKG2A blocking mAb, increases IFN-gamma production, thereby promoting NK cell effector functions. Monalizumab can be used for the research of head and neck squamous cell carcinoma (HNSCC)[1][2].

-80°C

41116161